Separate names with a comma.
Discussion in 'Allergan' started by anonymous, Jan 3, 2018 at 3:17 PM.
Just terrible. Appeasing the board and Wall Street.
Ireland-based Allergan, maker of Botox, expects the move to save it $300 million to $400 million this year. It anticipates the changes will cost $125 million, mainly due to severance expenses, the bulk of which is expected to be recorded in the fourth quarter.
The company said in November that it would undertake a cost-cutting and restructuring program, with CEO Brent Saunders telling analysts on an earnings call that Allergan was still in the planning phases but it saw "potential opportunities to become even more efficient."
Shares of Allergan have fallen more than 20 percent in the last 12 months. They were up 1.1 percent midday Wednesday.
When will we find out if we are on the hit list I left my manager a voice mail, no response yet!
And your Manager won’t call you back. You’ll find out tomorrow like the rest of us.
Tax Reform will be huge for us. I look forward to my future here at Allergan. Very bright skies ahead!
So who are the intended targets for these cuts? Sales? Irvine? R&D? Who's lives will be impacted this time? F'ing Allergan and their F'ed up management!
Did you not attend the Town Hall webcast today? Every detail was explained on it
For those that couldn't get on, can someone summarize?
You’ll find out tomorrow
Get lost creep !
You think tomorrow?
Everyone will be notified by Jan 12th.
And later in the year the sales force will expand again. Wash, rinse, repeat.
Someone already on my team lined up a new job.
expand sales force on drugs we are losing patents? are you a moron?